VIMAB Group Valuation
| VIMAB Stock | 7.90 0.05 0.63% |
At this time, the company appears to be overvalued. VIMAB Group AB has a current Real Value of USD7.58 per share. The regular price of the company is USD7.9. Our model measures the value of VIMAB Group AB from examining the company fundamentals such as price to book of 2.44 X, and Return On Equity of 2.92 as well as evaluating its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that VIMAB Group's price fluctuation is very risky at this time. Calculation of the real value of VIMAB Group AB is based on 3 months time horizon. Increasing VIMAB Group's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the VIMAB stock is determined by what a typical buyer is willing to pay for full or partial control of VIMAB Group AB. Since VIMAB Group is currently traded on the exchange, buyers and sellers on that exchange determine the market value of VIMAB Stock. However, VIMAB Group's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.9 | Real 7.58 | Hype 7.9 |
The intrinsic value of VIMAB Group's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence VIMAB Group's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of VIMAB Group AB helps investors to forecast how VIMAB stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of VIMAB Group more accurately as focusing exclusively on VIMAB Group's fundamentals will not take into account other important factors: VIMAB Group Total Value Analysis
VIMAB Group AB is at this time projected to have takeover price of 202.7 M with market capitalization of 195.96 M, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the VIMAB Group fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
202.7 M | 195.96 M |
VIMAB Group Asset Utilization
One of the ways to look at asset utilization of VIMAB is to check how much profit was generated for every dollar of assets it reports. VIMAB Group AB has a negative utilization of assets of -0.0135 %, losing USD1.35E-4 for each dollar of assets held by the company. Unsuccessful asset utilization indicates the company is being less competent with each dollar of assets it has. In other words, asset utilization of VIMAB Group AB shows how unproductive it operates for each dollar spent on its assets.VIMAB Group Ownership Allocation
VIMAB Group AB shows a total of 19.4 Million outstanding shares. VIMAB Group AB has 7.69 % of its outstanding shares held by insiders and 0.0 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.About VIMAB Group Valuation
The stock valuation mechanism determines VIMAB Group's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of VIMAB Group AB based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of VIMAB Group. We calculate exposure to VIMAB Group's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of VIMAB Group's related companies.8 Steps to conduct VIMAB Group's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates VIMAB Group's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct VIMAB Group's valuation analysis, follow these 8 steps:- Gather financial information: Obtain VIMAB Group's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine VIMAB Group's revenue streams: Identify VIMAB Group's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research VIMAB Group's industry and market trends, including the size of the market, growth rate, and competition.
- Establish VIMAB Group's growth potential: Evaluate VIMAB Group's management, business model, and growth potential.
- Determine VIMAB Group's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate VIMAB Group's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for VIMAB Stock Analysis
When running VIMAB Group's price analysis, check to measure VIMAB Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VIMAB Group is operating at the current time. Most of VIMAB Group's value examination focuses on studying past and present price action to predict the probability of VIMAB Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VIMAB Group's price. Additionally, you may evaluate how the addition of VIMAB Group to your portfolios can decrease your overall portfolio volatility.